Select Past Speakers
Drew Weissman*
Penn Medicine
*2023 Nobel Laureate
Katalin Karikó*
University of Pennsylvania
*2023 Nobel Laureate
Carolyn Bertozzi*
Stanford
*2022 Nobel Laureate
Emmanuelle Charpentier*
Max Planck Institute
*2020 Nobel Laureate
Jennifer Doudna*
UC Berkeley
*2020 Nobel Laureate
James Allison*
MD Anderson Cancer Center
*2018 Nobel Laureate
Carol Greider*
UCSC
*2009 Nobel Laureate
Jensen Huang
CEO, NVIDIA
Roy Cooper
Governor, North Carolina
Jay Bhattacharya
Director, NIH
Rob Califf
FDA Commissioner
Scott Gottlieb
FDA Commissioner
Francis S. Collins
Director, NIH
Carl June
University Pennsylvania
Anthony S. Fauci
US National Institute of Allergy and Infectious Disease (NIAID)
Seema Verma
CMS
Adrian Hill
University of Oxford
Hanneke Schuitemaker
Johnson and Johnson
Tal Zaks
Moderna
Philip Dormitzer
Pfizer
Jeffrey I. Gordon
Washington University in St. Louis
Mary V. Relling
St. Jude Children’s Research Hospital
Eric Topol
Scripps Research Institute
Feng Zhang
Broad Institute
Ugur Sahin
BioNTech
Özlem Türeci
BioNTech
Richard Schilsky
American Society of Clinical Oncology
Francis deSouza
Google Cloud
Lance Baldo
Adaptive Biotechnologies
Catherine Blish
Stanford University School of Medicine
Andrew von Eschenbach
Samaritan Health Initiatives, Inc.
Mathai Mammen
Johnson & Johnson
Akiko Iwasaki
Yale University
Peter Marks
FDA
Aaron Tobian
Johns Hopkins University School of Medicine
Ruth Clements
Quest Diagnostics
Sree Chaguturu
CVS Caremark
Eric Van Gieson
DARPA
Laurie H Glimcher
Dana-Farber Cancer Institute
Jill Hagenkord
Optum Genomics
Harpreet Singh Rai
Oura Ring
John Moore
Fitbit
Eran Segal
Weizmann Institute of Science
Julie Sunderland
Biomatics Capital
Steve Nelson
UnitedHealthcare
Arul M. Chinnaiyan
University of Michigan
Stephen Gruber
USC Norris Comprehensive Cancer Center
Jeffrey Leiden
Vertex Capital
Eric Lefkofsky
Tempus
Jenna Wiens
University of Michigan
Jeffrey Balser
Vanderbilt
James Allison
MD Anderson Cancer Center
Naomi Aronson
Blue Cross Blue Shield Association
Alan Ashworth
UCSF
Peter Bach
Memorial Sloan Kettering
Aris Baras
Regeneron Genetics Center
Todd Bauer
Sarah Cannon
Suzanne Belinson
Tempus, Inc
Sir John Bell
Oxford University
Jonathan S. Berg
UNC-Chapel Hill
Anna Berry
Swedish Cancer Institute
Roy Beveridge
Humana
Kimberly Blackwell
Tempus Labs, Inc.
Chris Boshoff
Pfizer Inc.
Julie Louise Gerberding
Merck
Brook Byers
KPCB
Dame Fiona Caldicott
Oxford University Hospitals NHS Trust
Robert M. Califf
Verily Life Sciences
Lon Cardon
BioMarin Pharmaceutical Inc.
Ballantine Carter
Johns Hopkins University
Tom Caskey
Baylor College of Medicine
Mark Caulfield
Genomics England
Emmanuelle Charpentier
Max Planck Institute
Daniel S. Chen
IGM Bioscience
Charles Chiu
UCSF School of Medicine
George Church
Human Genome Project
Carolyn Compton
Max Planck Institute
Susan A. Murphy
Harvard University
Lawrence Corey
Fred Hutchinson Cancer Research Center
William Dalton
M2Gen
Heidi L Rehm
Massachusetts General Hospital
Dame Mary Archer
Cambridge Healthcare Ltd.
Rade Drmanac
Complete Genomics, Inc. (a BGI company)
Brian Druker
OHSU
George D. Yancopoulos
Regeneron Pharmaceuticals, Inc.
George Demetri
Dana-Farber/Harvard
Ronald A. DePinho
MD Anderson Cancer Center
Luis Alberto Diaz
MSKCC
William Edenfield
Greenville Health System
Kojo Elenitoba-Johnson
Pennsylvania University
Laura Esserman
UCSF
Jay T. Flatley
Illumina
Isaac Garcia-Murillas
Institute of Cancer Research, UK
Kathy Giusti
Multiple Myeloma Research Foundation
Christopher P Boone
Abbvie
Joe Gray
Oregon Health & Science University
Eric Green
National Human Genome Research Institute
Professor Dame Anna Dominiczak
University of Glasgow
Steve Miller
Cigna Corporation
Alberto Gutierrez
FDA
Magaret Hamburg
Former FDA Commissioner
Yiwu He
The University of Hong Kong
James Herman
Johns Hopkins Medical Institutions
Lee Hood
Providence Health
Kathy Hudson
National Institutes of Health
Howard Jacob
AbbVie
Robert Jesse
Department of Veterans Affairs
Raghu Kalluri
MD Anderson
Brian Kelly
IQVIA
Edward S. Kim
Levine Cancer Institute
Richard Klausner
Lyell Immunopharma
Mary E. Klotman
Duke University School of Medicine
Andres Hurtado-Lorenzo
Crohn’s & Colitis Foundation
Harlan M. Krumholz
Yale School of Medicine
Michael Kolodziej
Aetna
Debbie Law
Bristol Myers Squibb
David Ledbetter
Dascena
Emily Leproust
Twist Bioscience
Mark Levis
Johns Hopkins University
Ronald Levy
Stanford University
Shari M. Ling
Centers for Medicare and Medicaid Services
Crystal L. Mackall
Stanford Universit
Elizabeth Mansfield
FDA Center for Devices
Elaine R. Mardis
Nationwide Children’s Hospital
Ira Mellman
Genentech
Duncan MacCannell
Centers for Disease Control and Prevention
Jessica Mega
Verily
Lincoln Nadauld
Intermountain Healthcare
Marc Harrison
Intermountain Healthcare
Marcia Eisenberg
LabCorp
John Niederhuber
Inova Translational Medicine Institute
Boris Pasche
Wake Forest Baptist Health
Scott Patterson
Gilead Sciences
Harold L. Paz
Aetna
Michael Pellini
Section 32
Roger Perlmutter
Merck Research Laboratories
David Persing
Cepheid
Hasso Plattner
SAP
Kim Popovits
Genomic Health
George Poste
Arizona State University
Lita M. Proctor
Human Microbiome Project
Jaewon Ryu
Geisinger
William (Bill) L. Roper
UNC Health Care System
Eric H. Rubin
Merck
Sharon Peacock
COVID-19 Genomics UK Consortium
Yvonne Maldonado
Stanford University School of Medicine
Howard I. Scher
Memorial Sloan Kettering Cancer Center
Eric Schadt
Sema4
Randy Scott
Invitae Corporation
Dennis Slamon
UCLA Cancer Center
Ralph Snyderman
Duke University
George Sledge
Stanford University
Kári Stefánsson
deCODE Genetics
Amy Compton-Phillips
Providence St. Joseph Health
John Strickler
Duke Cancer Institute
Joel Dudley
Tempus
Sean Tunis
Center for Medical Technology Policy
Irv Weissman
Stanford School of Medicine
Patrick Conway
Optum
Anne Wojcicki
23andMe
Janet Woodcock
FDA
Krishna Yeshwant
Google Ventures
Peter Paul Yu
Hartford HealthCare
Philip Greenberg
Fred Hutchinson Cancer Research Center
Joshua Denny
All of Us, NIH
Amy P. Abernethy
Healthcare Leader
Rodney F. Hochman
Providence St. Joseph Health
